for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Sihuan Pharmaceutical Holdings Group Ltd

0460.HK

現在値

0.81HKD

変化

-0.03(-2.99%)

出来高

14,935,000

本日のレンジ

0.81

 - 

0.85

52週レンジ

0.71

 - 

1.22

∙ 約20分前の相場を表示しています。

適時開示

Sihuan Pharma Announces Interim Cash Dividend And Special Cash Dividend

Aug 25 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::INTERIM CASH DIVIDEND OF RMB0.1 CENTS AND A SPECIAL CASH DIVIDEND OF RMB3.0 CENTS PER SHARE DECLARED.HY REVENUE RMB 1.05 BILLION VERSUS RMB 1.66 BILLION.HY PROFIT ATTRIBUTABLE RMB 170.5 MILLION VERSUS LOSS OF RMB 2 BILLION.

Sihuan Pharmaceutical Holdings Group Posts FY Loss Attributable Rmb2.75 Bln

March 24 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::RECOMMENDS DECLARATION AND PAYMENT OF A FINAL CASH DIVIDEND OF RMB1.3 CENTS PER SHARE.REVENUE FOR YEAR DECREASED BY 1.0% TO ABOUT RMB2,887.0 MLN.FY LOSS ATTRIBUTABLE RMB2.75 BILLION VERSUS PROFIT OF RMB1.62 BILLION.

Sihuan Pharmaceutical Says Drug Registration Approval Been Granted By NMPA For Group's Pediatric Compound Amino Acid Injection

March 23 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::SIHUAN PHARMACEUTICAL HOLDINGS GROUP- DRUG REGISTRATION APPROVAL HAS BEEN GRANTED BY NMPA OF PRC FOR GROUP'S PEDIATRIC COMPOUND AMINO ACID INJECTION.

Sihuan Pharmaceutical Holdings Group Says Clinical Research Of Favipiravir Has Commenced

March 2 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::CLINICAL RESEARCH OF FAVIPIRAVIR, A DRUG FOR CORONAVIRUS DISEASE HAS COMMENCED.

Sihuan Pharmaceutical To Buy All Interests And Intellectual Property Rights Of Plazomicin

Feb 20 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::ACQUIRED ALL INTERESTS AND INTELLECTUAL PROPERTY RIGHTS OF PLAZOMICIN FROM ACHAOGEN, INC..EXPECTS PLAZOMICIN WILL GENERATE SIGNIFICANT ECONOMIC BENEFITS AFTER LAUNCH IN GREATER CHINA.CO'S BENAPENEM COMMENCED PHASE II CLINICAL TRIALS FOR COMPLEX URINARY TRACT INFECTIONS IN PRC.

Sihuan Pharmaceutical Holdings Group Says Levetiracetam Tablet Gets Drug Production Approval

Feb 18 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::RIVASTIGMINE HYDROGEN TARTRATE CAPSULE & LEVETIRACETAM TABLET GET DRUG PRODUCTION APPROVAL BY NMPA.MIDAZOLAM OROMUCOSAL SOLUTION GRANTED DRUG REGISTRATION APPROVAL BY NMPA OF PRC.

Sihuan Pharmaceutical Holdings Reached Framework Cooperation Agreement In Pharmaceutical Manufacturing Area

Feb 11 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::GROUP & HETERO LABS LTD REACHED A FRAMEWORK COOPERATION AGREEMENT IN PHARMACEUTICAL MANUFACTURING AREA.BOTH PARTIES AGREED TO TAKE INTRODUCTION, DEVELOPMENT AND PRODUCTION OF NEW CORONAVIRUS DRUGS AS PRIORITY ISSUE.DEAL INCLUDES COMMERCIALIZATION OF DRUGS IN FIELDS OF ANTI-INFECTIVES INCLUDING NOVEL CORONAVIRUS, AMONG OTHERS.HETERO'S ANTI-VIRAL & ANTI-INFECTION PRODUCTS WILL BE INTRODUCED TO CHINA BY CO.

Sihuan Pharmaceutical Says Drug Registration Approval Granted For Quetiapine Fumarate Er Tablet

Aug 27 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::DRUG REGISTRATION APPROVAL GRANTED FOR QUETIAPINE FUMARATE ER TABLET.

Sihuan Pharmaceutical Holdings Group Ltd Posts HY Revenue Of Rmb1,662.3 Mln

Aug 19 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::HY REVENUE OF GROUP INCREASED BY 30.0% TO RMB1,662.3 MILLION.INTERIM DIVIDEND OF RMB0.4 CENTS PER SHARE WAS DECLARED BY BOARD.HY LOSS ATTRIBUTABLE RMB2.02 BILLION VERSUS PROFIT OF RMB765.7 MILLION.

Sihuan Pharma Holdings Group Says Unit, Strides Pharma Global Establish JV

July 30 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd <0460.HK>::JOINT VENTURE HAS BEEN ESTABLISHED BY UNIT SUN MORAL INTERNATIONAL AND STRIDES PHARMA GLOBAL PTE LIMITED.JOINT VENTURE IS OWNED AS TO 51% AND 49% BY SUN MORAL INTERNATIONAL AND STRIDES SINGAPORE SUBSIDIARY RESPECTIVELY.JOINT VENTURE WILL BE PRINCIPALLY ENGAGED IN BUSINESS OF REGISTRATION AND SALES FOR DRUGS.SJV WILL BE GIVEN EXCLUSIVE RIGHTS TO REGISTER, COMMERCIALIZE AND DISTRIBUTE FOUR PRODUCTS OF STRIDES IN CHINA.

金融情報はリフィニティブから。すべての情報は少なくとも20分遅れで表示されています。

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up